缓解和管理与amivantamab治疗相关的不良事件
Narjust Florez1,2, Nicole R LeBoeuf1,3, Julia Rotow1
1Dana-Farber Cancer Institute, Boston, MA, USA.
The oncologist
|July 1, 2025
概括
阿米万塔马布是一种针对EGFR和MET的双特异性抗体,为非小细胞肺癌提供了新的治疗选择. 了解和管理其独特的不良反应是维持患者治疗和生活质量的关键.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 阿米万塔马布是一种新型双特异性抗体,向表皮生长因子受体 (EGFR) 和介质细胞-表皮转变 (MET) 受体.
- 它已被批准用于高级或转移性非小细胞肺癌 (NSCLC),具有特定的EGFR突变 (外因子19缺失或L858R替代) 和MET外因子20插入突变.
研究的目的:
- 总结关于预防和管理与阿米万塔马布治疗方案相关的不良反应的建议.
- 为医疗保健提供者提供基于已发布的指导方针和临床经验的指导.
主要方法:
- 对阿米万塔马布的已公布治疗指南的审查.
- 关于不良事件管理的临床经验综合.
- 与EGFR和MET抑制相关的常见不良反应的识别.
主要成果:
- 常见的不良反应包括EGFR相关的皮肤反应 (皮疹,,) 和MET相关的效应 (外周,低albuminemia),以及输液相关的反应.
- 预防和管理策略对于减轻这些副作用至关重要.
结论:
- 有效地管理amivantamab独特的不良反应对于治疗坚持和改善患者生活质量至关重要.
- 了解潜在的副作用可以进行主动干预,优化高级NSCLC患者的治疗结果.
更多相关视频
相关概念视频
Pharmacovigilance
1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Myocarditis III: Medical Management
18
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
18
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
459
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
459
Myocarditis IV: Nursing Management
36
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
36
Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667
Anticholinesterase Agents: Poisoning and Treatment
1.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K


